{"slug":"tb-500-sciatica","verification":{"valid":true,"entries":5,"head":"92b76ebcaad18180c18091d0b8cfb53a2fefe6cc34cc62d006840bc3a1fa3c10"},"count":5,"sources":[{"id":"s3","type":"pubmed","url":"https://www.mdpi.com/2076-3417/16/12/6202","title":"Thymosin Beta-4 and TB-500 in Tissue Healing ...","quote":"No human interventional studies of administered TB4 or TB-500 were identified in tendon, ligament, muscle, bone, cartilage, adipose/fat graft, or spine/intervertebral disc categories","summary":"Systematic mapping of 80 studies showing sparse human musculoskeletal data for TB-500/TB4.","claim_ids":["c1","c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:31:44.584Z","link_status":"http_403","quote_status":"unverified","prev":"genesis","hash":"d0636167eadced33e2311737b98f9ad6e55bcac240a689ecd512d440896ca1f8"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19903499/","title":"Peptide therapy with pentadecapeptide BPC 157 in ...","quote":"BPC 157 markedly improved rat sciatic nerve healing.","summary":"2010 rat study on transected sciatic nerve showing improved regeneration with BPC-157.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:31:44.584Z","link_status":"ok","quote_status":"verified","prev":"d0636167eadced33e2311737b98f9ad6e55bcac240a689ecd512d440896ca1f8","hash":"1b7a2d1cb09099956db106dabe3859f52de62453c48bed17a5d13017717fa78c"},{"id":"s19","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3563705/","title":"Safety and Efficacy of ARA 290 in Sarcoidosis Patients ...","quote":"We studied the safety and efficacy of ARA 290 to reduce symptoms of small fiber neuropathy (SFN) in patients with sarcoidosis.","summary":"Human trial of ARA-290 in sarcoidosis SFN patients.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:31:44.584Z","link_status":"ok","quote_status":"verified","prev":"1b7a2d1cb09099956db106dabe3859f52de62453c48bed17a5d13017717fa78c","hash":"87d25b3fe87154e9e2e731a801db2354e4e13e5954b3909b2b048ca8f97d85ff"},{"id":"s21","type":"pubmed","url":"https://journals.lww.com/painrpts/fulltext/2016/08000/targeting_the_innate_repair_receptor_to_treat.2.aspx","title":"Targeting the innate repair receptor to treat neuropathy","quote":"In humans, ARA290 has been evaluated in patients with small fiber neuropathy associated with sarcoidosis or type 2 diabetes (T2D) mellitus.","summary":"Review summarizing human ARA-290 neuropathy trials.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:31:44.584Z","link_status":"ok","quote_status":"verified","prev":"87d25b3fe87154e9e2e731a801db2354e4e13e5954b3909b2b048ca8f97d85ff","hash":"cce79aea7829ef48719489021780adad1295c9aeacb09d548e44d42f8427787c"},{"id":"s18","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40131143/","title":"Safety of Intravenous Infusion of BPC157 in Humans","quote":"Intravenous infusion of up to 20 mg of BPC-157 in 2 healthy adults showed no adverse effects and was well-tolerated.","summary":"Pilot human safety study of BPC-157 IV.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:31:44.584Z","link_status":"ok","quote_status":"verified","prev":"cce79aea7829ef48719489021780adad1295c9aeacb09d548e44d42f8427787c","hash":"92b76ebcaad18180c18091d0b8cfb53a2fefe6cc34cc62d006840bc3a1fa3c10"}]}